Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilitiesJohannes Foßelteder, Andreas Reinisch, Lisa Auinger et al.|Leukemia|2023Cited by 20
Introduction and Genetic Correction of Calreticulin Mutations in Human Hematopoietic Stem and Progenitor Cells Sheds Light on MPN PathogenesisJohannes Foßelteder, Andreas Reinisch, Angelika Schlacher et al.|Blood|2021Cited by 0